Literature DB >> 2920757

Vitamin D metabolism in tumoral calcinosis.

R Steinherz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2920757     DOI： 10.1007/BF00595920

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

1.  Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

Authors:  A Metzker; B Eisenstein; J Oren; R Samuel
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

2.  The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.

Authors:  R W Gray; D R Wilz; A E Caldas; J Lemann
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

3.  Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis.

Authors:  R Steinherz; R W Chesney; B Eisenstein; A Metzker; H F DeLuca; M Phelps
Journal:  Am J Dis Child       Date:  1985-08

4.  Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action.

Authors:  E G Lufkin; R Kumar; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

5.  Tumoral calcinosis: evidence for concurrent defects in renal tubular phosphorus transport and in 1 alpha,25-dihydroxycholecalciferol synthesis.

Authors:  J E Zerwekh; L A Sanders; J Townsend; C Y Pak
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

6.  Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations.

Authors:  M J Prince; P C Schaeffer; R S Goldsmith; A B Chausmer
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.